Virus Outbreak Malaria Drug
In a nationwide study of 368 patients in U.S. veterans hospitals, 28% who received hydroxychloroquine and usual care died, versus 11% of those getting only routine care.
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported.
The nationwide study was not a rigorous experiment. But with 368 patients, it’s the largest look so far of hydroxychloroquine with or without the antibiotic azithromycin for COVID-19, which has killed more than 171,000 people as of Tuesday.
The study was posted on an online site for researchers and has has not been reviewed by other scientists. Grants from the National Institutes of Health and the University of Virginia paid for the work.
Researchers analyzed medical records of 368 male veterans hospitalized with confirmed coronavirus infection at Veterans Health Administration medical centers who died or were discharged by April 11.
About 28% who were given hydroxychloroquine plus usual care died, versus 11% of those getting routine care alone. About 22% of those getting the drug plus azithromycin died too, but the difference between that group and usual care was not considered large enough to rule out other factors that could have affected survival.
Hydroxychloroquine made no difference in the need for a breathing machine, either.
Researchers did not track side effects, but noted a hint that hydroxychloroquine might have damaged other organs. The drug has long been known to have potentially serious side effects, including altering the heartbeat in a way that could lead to sudden death.
Earlier this month, scientists in Brazil stopped part of a study testing chloroquine, an older drug similar to hydroxychloroquine, after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested.
RELATED: Trump Won’t Stop Promoting Controversial Malaria Drug That Has Dangerous Side Effects
Many doctors have been leery of the drug.
At the University of Wisconsin, Madison, “I think we’re all rather underwhelmed” at what’s been seen among the few patients there who’ve tried it, said Dr. Nasia Safdar, medical director of infection control and prevention.
Patients asked about it soon after Trump started promoting its use, “but now I think that people have realized we don’t know if it works or not” and needs more study, said Safdar, who had no role in the VA analysis.
The NIH and others have more rigorous tests underway.
Politics
Opinion: The problem with Youngkin’s Charter-Lab schools push in 2024
The Problem Governor Glenn Youngkin introduced 233 amendments to the bipartisan budget so it was hard to know how to assess his budget–for example,...
What to know about Trump’s legal issues
Over the past year, former president Donald Trump has become the center of not one, not two, not three, but four criminal investigations, at both...
Local News
Virginia verses: Celebrating 5 poetic icons for National Poetry Month
There’s no shortage of great writers when it comes to our commonwealth. From the haunting verses of Edgar Allan Poe, who found solace in Richmond's...
Join the fun: Recapping Family Literacy Night’s storybook adventures
When’s the last time you read a book aloud with a loved one? If it’s difficult to answer that question, then maybe it’s time to dust off that TBR...